Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections

Stubbs BJ et al.

Med (New York, N.Y.)

Key finding

This review discusses the opportunities, risks and research gaps for using exogenous ketone bodies as immunometabolic interventions against influenza A and SARS-CoV-2, and the abstract reports no experimental findings.

What the study did

This review provides an overview of ketone body biology relevant to respiratory viral infection, focusing on influenza A and SARS-CoV-2. It describes ketone bodies as endogenous metabolites with signaling activities that affect immune activity, metabolism and epigenetics. It discusses the opportunities, risks and research gaps in studying exogenous ketone bodies as immunometabolic interventions. The abstract reports no experimental results.

This study used [form], not goBHB. It is shown here as general ketone science. Only goBHB studies back goBHB product claims.

GOBHB//QUERY_CONSOLE271 STUDIES INDEXED

> Ask what it does, which formats it goes into, or who is already using it.

What does BHB do?goBHB in gummies?Who is using goBHB?

Let me put a person on it

A goBHB specialist picks these up and answers inside one business day.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Pharmaceutical grade, 48 patents, and over 300 million doses in market.

Ask me about goBHB